Size and conformational stability of the hepatitis A virus used to prepare VAQTA, a highly purified inactivated vaccine

Journal of Pharmaceutical Sciences

Volumn 86, Issue 6, 1997, Pages 666-673

  Volkin, David B ^a   Burke, Carl J ^a   Marfia, Kimberly E ^a   Oswald, C Brent ^a   Wolanski, Bohdan ^a   Middaugh, C Russell ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ARTICLE; CIRCULAR DICHROISM; DRUG STABILITY; ELECTRON MICROSCOPY; HEPATITIS A VIRUS; HUMAN; LIGHT SCATTERING; PARTICLE SIZE; THERMOSTABILITY; ULTRAVIOLET SPECTROSCOPY; VACCINE PRODUCTION; VIRUS INACTIVATION; VIRUS PARTICLE; VIRUS VIRULENCE;

EID: 0031011382     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960475h     Document Type: Article

References (41)

1. Melnick, J. L. Prog. Med. Virol. 1990, 37, 47-55.
2. Ross B. C.; Anderson, D. A.; Gust, I. D. Adv. Virus Res. 1991, 39, 209-253.
3. Lemon, S. M. Med. Virol. 1992, 2, 73-87.
4. Werzberger, A.; Mensch, B.; Kuter, B.; Brown, L.; Lewis, J.; Sitrin, R.; Miller, W.; Shouval, D.; Wiens, B.; Calandra, G.; Ryan, J.; Provost, P.; Nalin, D. N. Eng. J. Med. 1992, 327 453-457.
5. Aboud, R. A.; Aunins, J. G.; Buckland, B. C.; DePhillips, P. A.; Hagen, A. J.; Hennessey, J. P.; Junker, B.; Lewis, J. A.; Oliver, C. N.; Orella C. J.; Sitrin, R. D. Patent Application 1994, WO 94/03589.
6. Armstrong, M. E.; Giesa, P. A.; Davide, J. P.; Redner, F.; Waterbury, J. A.; Rhoad, A. E.; Keys, R. D.; Provost P. J.; Lewis, J. A. J. Hepatol. 1993, 18 (Suppl. 2), S20-S26.
7. Hagen, A. J.; Aboud, R. A.; DePhillips, P. A.; Oliver C. N.; Orella, C. J.; Sitrin, R. D.; Biotechnol. Appl. Biochem. 1996, 23, 209-215.
8. Hagen, A. J.; Oliver, C. N.; Sitrin, R. D. Biotech. Prog. 1996, 12, 406-412.
9. Hagen, A. J.; Oliver, C. N.; Sitrin, R. D. Biotech. Bioeng. In press.
10. Melnick, J. L. Mol. Virol. 1992, 10, 24-26.
11. Gust, I. D.; Feinstone, S. M. in Hepatitis A; CRC Press: Boca Raton, FL, 1988; pp 199-143.
12. Gust, I. D.; Feinstone, S. M. in Hepatitis A; CRC Press: Boca Raton, FL, 1988; pp 41-59.
13. Coulepis, A. G.; Locarnini, S. A.; Westaway, E. G.; Tannock, G. A.; Gust, I.D. Intervirology 1982, 18, 107-127.
14. Putnak J. R.; Phillips, B. A. Microbiol. Rev. 1981, 45, 287-315.
15. Muller, V. G.; Lottspeich, F.; Deinhardt, F. Virology 1986, 155, 732-736.
16. Siegl, G.; Frosner, G. G.; Gauss-Muller, V.; Tratschin, J-D.; Deinhardt, F. J. Gen. Virol. 1981, 57, 331-341.
17. Kurstak, E. in Viral Hepatitis; Springer-Verlag Wien: New York, 1993, pp 13-58.
18. Provost, P. J.; Wolanski, B. S.; Miller, W. J.; Ittensohn, O. L.; McAleer W.J.; Hilleman, M. R. Proc. Soc. Exp. Biol. Med. 1975, 148, 532-539.
19. Siegl, G.; Weitz M.; Kronauer, G. Intervirology 1984, 22, 218-226.
20. Parry J. V.; Mortimer, P. P. J. Med. Virol. 1984, 14, 277-283.
21. Anderson, D. A. J. Med. Virol. 1987, 22, 35-44.
22. Scholz, E.; Heinricy, U.; Flehmig, B. J. Gen. Virol. 1989, 70, 2481-2485.
23. Newman, J. F. E.; Tirrell, S.; Ullman, C.; Piatti, P. G.; Brown, F. Vaccine 1995, 13, 1431-1435.
24. Rombaut, B.; Verheyden, B.; Andries, K.; Boeye, A. J. Virol. 1994, 68, 6454-6457.
25. Andries, K.; Rombaut, B.; Dewindt, B.; Boeye, A. J. Virol. 1994, 68, 3397-3400.
26. Twomey, T.; Newman, J.; Burrage, T.; Piatti, P.; Lubroth, J.; Brown, F. Vaccine 1995, 13, 1603-1610.
27. Wang, C.-H.; Tschen, S.-Y.; Flehmig, B. Vaccine 1995, 13, 835-840.
28. Andre, F. E. J. Infect. Dis. 1995, 171 (Suppl 1), S33-S39.
29. Stafford, W. F. Anal. Biochem. 1992, 203, 295-302.
30. Mesyanzhinov, V. V.; Peletskaya, E. N.; Zhdanov V. M.; Efimou, A. V.; Finkelstein, A. V.; Ivanovsky, D. I. J. Biomol. Struct. Dynam. 1987, 5, 447-458.
31. Hogle, J. M.; Chow M.; Filman, D. J. Science 1986, 229, 1358-1365.
32. France, L. L.; Piatti, P. G.; Newman, J. F. E.; Toth, I.; Gibbons, W. A.; Brown, F. Proc. Natl. Acad. Sci. U.S.A. 1994, 97, 8442-8446.
33. Dorval, B. L.; Chow M.; Klibanov, A. M. Biotech. Bioeng. 1990, 35, 1051-1084.
34. Gruenberger, M.; Pevear, D.; Diana, G. D.; Kuechler E.; Blaas, D. J. Gen. Virol. 1991, 72, 431-433.
35. Grimmel, M.; Zibirre, R.; Koch, G. Arch. Virol., 1983, 78, 191-201.
36. Wu, R.; Georgescu, M. M.; Delpeyroux F.; Guillot, S.; Balanant, J.; Simpson, K.; Crainic, R.; Vaccine 1995, 13, 1058-1063.
37. Volkin, D. B.; Mach, H.; Middaugh, C. R. Meth. Mol. Biol. 1995, 40, 35-63.
38. Razdan, R.; Sen, A. K.; Rao, B. V.; Suryanarayana, V. V. S. Acta. Virolog. 1996, 40 9-14.
39. Cleland, J. L.; Powell, M. F.; Shire, S. J. Crit. Rev. Ther. Drug Carrier Systems 1993, 10, 307-377.
40. Volkin, D. B.; Sanyal, G.; Burke, C. J; Middaugh, C. R. in Formulation Development and Manufacure of Protein Pharmaceuticals; Plenum Press, New York, in press.
41. Volkin, D. B.; Burke, C. J.; Sanyal, G.; Middaugh, C. R. Dev. Biol. Stand. 1996, 87, 135-142.